BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25642111)

  • 1. Provide optimized antidepressant monotherapy with multiple drugs before considering antidepressant polypharmacy.
    Saah T; Garlow SJ; Rapaport MH
    Shanghai Arch Psychiatry; 2014 Dec; 26(6):360-2. PubMed ID: 25642111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
    Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN
    CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When is antidepressant polypharmacy appropriate in the treatment of depression?
    Si T; Wang P
    Shanghai Arch Psychiatry; 2014 Dec; 26(6):357-9. PubMed ID: 25642110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 Oct; 73(10):1300-6. PubMed ID: 23140647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication options in the treatment of treatment-resistant depression.
    Pridmore S; Turnier-Shea Y
    Aust N Z J Psychiatry; 2004 Apr; 38(4):219-25. PubMed ID: 15038800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder.
    Gruber AJ; Hudson JI; Pope HG
    Psychiatr Clin North Am; 1996 Jun; 19(2):351-69. PubMed ID: 8827194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing augmentation with non-antidepressants over sticking to antidepressants after treatment failure in depression: a naturalistic study.
    Köhler S; Unger T; Hoffmann S; Steinacher B; Fydrich T; Bschor T
    Pharmacopsychiatry; 2013 Mar; 46(2):69-76. PubMed ID: 23093475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders.
    Rhee TG; Rosenheck RA
    J Affect Disord; 2019 Jun; 252():450-457. PubMed ID: 31004825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing the choice of antidepressants: a study of antidepressant prescribing practice at University Psychiatric Clinic in Belgrade.
    Marić NP; Stojiljković DJ; Pavlović Z; Jasović-Gamsić M
    Vojnosanit Pregl; 2012 Apr; 69(4):308-13. PubMed ID: 22624421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining antidepressants.
    Dunner DL
    Shanghai Arch Psychiatry; 2014 Dec; 26(6):363-4. PubMed ID: 25642112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring patients on chronic treatment with antidepressants between 2003 and 2011: analysis of factors associated with compliance.
    Serna MC; Real J; Cruz I; Galván L; Martin E
    BMC Public Health; 2015 Nov; 15():1184. PubMed ID: 26611468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression.
    Bobo WV; Shelton RC
    Expert Rev Neurother; 2010 May; 10(5):651-70. PubMed ID: 20420487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition and management of depression in primary care: a focus on the elderly. A pharmacotherapeutic overview of the selection process among the traditional and new antidepressants.
    Barkin RL; Schwer WA; Barkin SJ
    Am J Ther; 2000 May; 7(3):205-26. PubMed ID: 11317169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of standard depression therapy.
    Marangell LB
    Clin Ther; 2000; 22 Suppl A():A25-38; discussion A39-41. PubMed ID: 10815648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using adjunctive treatments when first-line antidepressants fail.
    Thase ME
    J Clin Psychiatry; 2012 Jan; 73(1):e01. PubMed ID: 22316580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why isn't bupropion the most frequently prescribed antidepressant?
    Zimmerman M; Posternak MA; Attiullah N; Friedman M; Boland RJ; Baymiller S; Berlowitz SL; Rahman S; Uy KK; Singer S; Chelminski I
    J Clin Psychiatry; 2005 May; 66(5):603-10. PubMed ID: 15889947
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.